217 related articles for article (PubMed ID: 31667735)
1. Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects.
Harada A; Ikushima I; Haranaka M; Yanagihara A; Nakayama D
Am J Cardiovasc Drugs; 2020 Jun; 20(3):249-258. PubMed ID: 31667735
[TBL] [Abstract][Full Text] [Related]
2. Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers.
Chan N; Wheeler M; Bhagirath V; Bosch J; Heinrich-Nols J; Sloane D; van Ryn J; Jefferies L; Wilkinson J; Yi Q; Eikelboom J
CJC Open; 2023 Jan; 5(1):1-7. PubMed ID: 36700178
[TBL] [Abstract][Full Text] [Related]
3. Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmacokinetics of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension.
Thyssen A; Solanki B; Treem W
Clin Ther; 2012 Jul; 34(7):1636-45. PubMed ID: 22748970
[TBL] [Abstract][Full Text] [Related]
4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults-cross-study comparison.
Thyssen A; Solanki B; Gonzalez M; Leitz G; Treem W; Mannaert E
Clin Pharmacol Drug Dev; 2014 Sep; 3(5):406-16. PubMed ID: 27129014
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence and pharmacodynamics of a generic dabigatran etexilate capsule in healthy Chinese subjects under fasting and fed conditions.
Li X; Liu L; Xu B; Xiang Q; Li Y; Zhang P; Wang Y; Xie Q; Mao Y; Cui Y
Pharmacol Res Perspect; 2020 Apr; 8(2):e00593. PubMed ID: 32338459
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
Shaik N; Hee B; Wei H; LaBadie RR
Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
[TBL] [Abstract][Full Text] [Related]
8. Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.
Halton JML; Albisetti M; Biss B; Bomgaars L; Brueckmann M; Gropper S; Harper R; Huang F; Luciani M; Maas H; Tartakovsky I; Mitchell LG
J Thromb Haemost; 2017 Nov; 15(11):2147-2157. PubMed ID: 28921890
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism.
Halton JML; Picard AC; Harper R; Huang F; Brueckmann M; Gropper S; Maas H; Tartakovsky I; Nurmeev I; Mitchell LG; Brandão LR; Chalmers E; Albisetti M
Thromb Haemost; 2017 Nov; 117(11):2168-2175. PubMed ID: 29202215
[TBL] [Abstract][Full Text] [Related]
10. Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study).
Takeuchi T; Furuta T; Fujiwara Y; Sugimoto M; Kasugai K; Kusano M; Okada H; Suzuki T; Higuchi T; Kagami T; Uotani T; Yamade M; Sawada A; Tanaka F; Harada S; Ota K; Kojima Y; Murata M; Tamura Y; Funaki Y; Kawamura O; Okamoto Y; Fujimoto K; Higuchi K
Aliment Pharmacol Ther; 2020 Mar; 51(5):534-543. PubMed ID: 31990424
[TBL] [Abstract][Full Text] [Related]
11. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors.
Ollier E; Hodin S; Basset T; Accassat S; Bertoletti L; Mismetti P; Delavenne X
Fundam Clin Pharmacol; 2015 Dec; 29(6):604-14. PubMed ID: 26392328
[TBL] [Abstract][Full Text] [Related]
13. Absolute bioavailability and effect of formulation change, food, or elevated pH with rabeprazole on cobimetinib absorption in healthy subjects.
Musib L; Choo E; Deng Y; Eppler S; Rooney I; Chan IT; Dresser MJ
Mol Pharm; 2013 Nov; 10(11):4046-54. PubMed ID: 24010577
[TBL] [Abstract][Full Text] [Related]
14. Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.
Faber KP; Wu HF; Yago MR; Xu X; Kadiyala P; Frassetto LA; Benet LZ
Pharm Res; 2017 Mar; 34(3):619-628. PubMed ID: 28028768
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study.
Trivedi A; Kiang YH; Saw RE; Cheng GC; Mather O; Vega S; Hellawell J; Lee E
Drugs R D; 2022 Jun; 22(2):147-154. PubMed ID: 35412220
[TBL] [Abstract][Full Text] [Related]
17. Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics.
Ye N; Monk SA; Daga P; Bender DM; Rosen LB; Mullen J; Minkwitz MC; Kugler AR
Clin Pharmacol Drug Dev; 2018 Mar; 7(3):233-243. PubMed ID: 29319935
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
[TBL] [Abstract][Full Text] [Related]
19. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal Function.
Martin JL; Esmaeili H; Manuel RC; Petrini M; Wiebe S; Maas H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):399-406. PubMed ID: 29695165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
